News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,258 Results
Type
Article (88124)
Company Profile (825)
Press Release (783289)
Multimedia
Podcasts (203)
Webinars (29)
Section
Business (233328)
Career Advice (4151)
Deals (39890)
Drug Delivery (152)
Drug Development (91464)
Employer Resources (205)
FDA (18422)
Job Trends (17437)
News (398071)
Policy (39989)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3021)
Academic (2)
Accelerated approval (37)
Adcomms (36)
Allergies (158)
Alliances (56982)
ALS (186)
Alzheimer's disease (1820)
Antibody-drug conjugate (ADC) (364)
Approvals (18613)
Artificial intelligence (660)
Autoimmune disease (185)
Automation (45)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (210)
Biotechnology (490)
Bladder cancer (168)
Brain cancer (67)
Breast cancer (688)
Cancer (5225)
Cardiovascular disease (464)
Career advice (3575)
Career pathing (42)
CAR-T (316)
CDC (65)
Celiac Disease (2)
Cell therapy (864)
Cervical cancer (39)
Clinical research (77265)
Collaboration (1904)
Company closure (5)
Compensation (1218)
Complete response letters (78)
COVID-19 (3000)
CRISPR (105)
C-suite (940)
Cystic fibrosis (155)
Data (6522)
Decentralized trials (2)
Denatured (75)
Depression (159)
Diabetes (547)
Diagnostics (7288)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (323)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (251)
Earnings (100498)
Editorial (68)
Employer branding (25)
Employer resources (174)
Events (135554)
Executive appointments (1063)
FDA (21738)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1608)
Gene editing (226)
Generative AI (71)
Gene therapy (698)
GLP-1 (1150)
Government (5472)
Grass and pollen (8)
Guidances (388)
Healthcare (20972)
HIV (70)
Huntington's disease (51)
IgA nephropathy (89)
Immunology and inflammation (307)
Immuno-oncology (71)
Indications (122)
Infectious disease (3311)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (130)
Intellectual property (265)
Interviews (817)
IPO (17967)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (71)
Kidney cancer (18)
Labor market (97)
Layoffs (662)
Leadership (42)
Legal (10166)
Liver cancer (99)
Longevity (17)
Lung cancer (706)
Lymphoma (393)
Machine learning (45)
Management (66)
Manufacturing (902)
MASH (180)
Medical device (15074)
Medtech (15136)
Mergers & acquisitions (23021)
Metabolic disorders (1450)
Multiple sclerosis (174)
NASH (23)
Neurodegenerative disease (375)
Neuropsychiatric disorders (108)
Neuroscience (3211)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5120)
Now hiring (69)
Obesity (706)
Opinion (343)
Ovarian cancer (172)
Pain (222)
Pancreatic cancer (245)
Parkinson's disease (310)
Partnered (39)
Patents (538)
Patient recruitment (525)
Peanut (63)
People (67093)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23874)
Phase 2 (33529)
Phase 3 (25251)
Pipeline (5687)
Policy (352)
Postmarket research (3554)
Preclinical (10710)
Press Release (72)
Prostate cancer (257)
Psychedelics (60)
Radiopharmaceuticals (311)
Rare diseases (971)
Real estate (7443)
Recruiting (81)
Regulatory (29259)
Reports (69)
Research institute (2738)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (265)
Series B (205)
Service/supplier (30)
Sickle cell disease (107)
Special edition (28)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (4337)
State (2)
Stomach cancer (21)
Supply chain (115)
Tariffs (101)
The Weekly (126)
Vaccines (1184)
Venture capital (101)
Weight loss (485)
Women's health (102)
Worklife (22)
Date
Today (156)
Last 7 days (754)
Last 30 days (2619)
Last 365 days (32829)
2026 (4570)
2025 (33229)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (94)
Alaska (7)
Arizona (351)
Arkansas (15)
Asia (51651)
Australia (9074)
California (11956)
Canada (3425)
China (1209)
Colorado (506)
Connecticut (521)
Delaware (360)
Europe (118787)
Florida (1774)
Georgia (386)
Hawaii (4)
Idaho (68)
Illinois (997)
India (78)
Indiana (564)
Iowa (24)
Japan (454)
Kansas (135)
Kentucky (45)
Louisiana (30)
Maine (84)
Maryland (1494)
Massachusetts (8781)
Michigan (372)
Minnesota (678)
Mississippi (6)
Missouri (144)
Montana (36)
Nebraska (29)
Nevada (130)
New Hampshire (87)
New Jersey (3207)
New Mexico (33)
New York (3151)
North Carolina (1660)
North Dakota (10)
Northern California (5762)
Ohio (367)
Oklahoma (23)
Oregon (55)
Pennsylvania (2381)
Puerto Rico (25)
Rhode Island (51)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4626)
Tennessee (183)
Texas (1879)
United States (43071)
Utah (360)
Vermont (1)
Virginia (301)
Washington D.C. (88)
Washington State (1000)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
There are 872,258 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
February 24, 2026
·
11 min read
Press Releases
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
February 24, 2026
·
31 min read
Press Releases
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
February 24, 2026
·
4 min read
Press Releases
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March 2026
February 24, 2026
·
1 min read
Press Releases
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
February 24, 2026
·
13 min read
Press Releases
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
February 24, 2026
·
1 min read
Press Releases
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
February 24, 2026
·
3 min read
Manufacturing
Radiopharmaceutical Sector Shapes Supply Chain Around Fast-Decaying Products
The necessity of delivering medicine days after it’s produced drives decisions about where to build facilities and how to ship radioactive materials to healthcare providers.
February 24, 2026
·
3 min read
·
Nick Paul Taylor
Press Releases
RESTEM to Present at BIO Investment & Growth Summit 2026
February 23, 2026
·
1 min read
Press Releases
More Than 30 Million Americans Living with Rare Diseases
February 23, 2026
·
4 min read
1 of 87,226
Next
